Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer

NCT07551050 · clinicaltrials.gov ↗
RECRUITING
Status
300
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Fudan University